Catalyst Wire Dossier Catalyst Wire Dossier

Tafluprost (MK2452)

tafluprost · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tafluprost (MK2452), covering 2011-09-13 to 2011-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) [Phase 3]

See pricing